U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07697898) titled 'TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC' on July 07.
Brief Summary: This is a prospective, multicenter, observational cohort study of patients with esophageal squamous cell carcinoma who have received neoadjuvant immunochemotherapy and are scheduled to undergo curative esophagectomy with standard systematic lymphadenectomy.
The study will not alter the current standard surgical approach. All patients will receive curative esophagectomy and systematic lymph node dissection according to institutional practice. Lymph nodes will be separated and recorded by anatomical station during surgery, followed b...